WELL — WELL Health Technologies Income Statement
0.000.00%
Last trade - 00:00
- CA$871.77m
- CA$1.33bn
- CA$776.05m
- 60
- 60
- 67
- 65
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.8 | 50.2 | 302 | 569 | 776 |
Cost of Revenue | |||||
Gross Profit | 11 | 21.2 | 154 | 303 | 372 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 39.8 | 62.5 | 321 | 525 | 761 |
Operating Profit | -7.03 | -12.3 | -18.4 | 44.3 | 15.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.76 | -7.57 | -25.5 | 17.5 | 19.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.79 | -3.21 | -31.3 | 18.7 | 16.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -7.82 | -3.69 | -44.2 | 1.37 | 0.082 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.82 | -3.69 | -44.2 | 1.37 | 0.082 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.07 | -0.003 | -0.18 | -0.048 | 0.096 |